Galectin Therapeutics Inc. News
5 Top Stock Gainers for Friday: Stamps.com, Galectin, GM
Stamps.com, Galectin Therapeutics, General Motors, Far Peak Acquisition and Carver Bancorp are five top stock gainers for Friday.
Galectin Therapeutics Soars on Positive Melanoma Treatment Data
Galectin Therapeutics jumps after positive data from its melanoma treatment.
Galectin therapeutics (galt) stock drops on drug failure, downgraded
H.C. Wainwright reduced Galectin Thereapeutics' (GALT) stock rating to 'neutral' after the company's fatty liver disease drug failed in a phase II clinical trial.
Galectin therapeutics (galt) stock declines on drug failure, rating cut
Galectin Therapeutics' (GALT) stock rating was cut two notches to 'sell' at Roth Capital on Wednesday after the company's drug for fatty liver disease failed a clinical trial.
Top Swing Trade Ideas for Monday: Cerus, Endocyte, More
Cerus, Endocyte and Galectin Therapeutics are our big swing trades for Monday. So, how should investors buy and sell?
5 Breakout Stocks Under $10 Set to Soar
These under-$10 stocks look ready to break out and trade higher from current levels.
Why Galectin Therapeutics (GALT) Stock Is Plummeting Today
Galectin Therapeutics (GALT) plummeted Tuesday after the company reported poor results in an early-stage trial of its experimental drug for treatment of a fatty liver disease.
Galectin Drug is a Fatty Liver Flop
Across just about every biomarker for efficacy Galectin thought to measure, GR-MD-02 showed no difference from placebo in a phase I study.
Galectin Pays Stock Promoters to Entice Retail Investors
Like Galena BioPharma and The DreamTeam Group, Galectin is also paying for a promotional campaign designed to entice retail investors into buying its stock.
Intercept Rises After Analyst Targets Shares to More Than Double
Shares of drugmaker Intercept Pharmaceuticals (ICPT) are climbing after research firm Summer Street initiated coverage of the shares with a Buy rating and a $650 price target in a note to investors earlier today.
Breaking News
Target Stock Slides As Discounts Clip Margins, Sharply Trim Q2 Earnings
"While these inventory actions put significant pressure on our near-term profitability, we're confident this was the right long-term decision," said CEO Brian Cornell.
Taking Social Security? Retirees May Get a Big COLA Bump Up in 2023.
U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.
Wendy's Follows McDonald's in Making a Huge Change
Restaurants are moving to adapt to customers with very different wants and desires.
Amazon Makes Serious Accusations Against a Powerful Regulator
E-commerce giant Amazon is the subject of a major investigation linked to its Prime service. It's not sitting idly by.